Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.9T | 3.0T | 2.8T | 2.8T |
| Cost of revenue | 1.2T | 1.1T | 990.2B | 1.0T |
| Gross profit | 1.7T | 1.9T | 1.8T | 1.8T |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 538.5B | 498.4B | 358.9B | 327.7B |
| Other operating expenses | 10.6B | 9.3B | 10.6B | 10.0B |
| Operating income | -129.4B | -198.3B | 4.1B | 74.0B |
| Non operating interest income | ||||
| Income | 6.8B | 12.7B | 12.6B | 1.2B |
| Expense | 343.2B | 373.5B | 282.5B | 318.7B |
| Other income expense | — | — | — | — |
| Pretax income | -342.9B | -590.8B | -157.8B | -194.8B |
| Tax provision | -55.7B | -56.8B | 62.5B | 58.6B |
| Net income | -287.2B | -534.0B | -220.4B | -253.4B |
| Basic EPS | — | — | — | -0.8 |
| Diluted EPS | — | — | — | -0.8 |
| Basic average shares | — | — | — | 335.4B |
| Diluted average shares | — | — | — | 335.4B |
| EBITDA | 1.1T | 1.2T | 1.3T | 1.2T |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 17M | 15M | 12M | 10M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |